164 related articles for article (PubMed ID: 36631208)
1. Elevated LDL Triglycerides and Atherosclerotic Risk.
Balling M; Afzal S; Davey Smith G; Varbo A; Langsted A; Kamstrup PR; Nordestgaard BG
J Am Coll Cardiol; 2023 Jan; 81(2):136-152. PubMed ID: 36631208
[TBL] [Abstract][Full Text] [Related]
2. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
4. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
5. Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1144-1155. PubMed ID: 38511326
[TBL] [Abstract][Full Text] [Related]
6. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.
Hussain A; Sun C; Selvin E; Nambi V; Coresh J; Jia X; Ballantyne CM; Hoogeveen RC
Eur J Prev Cardiol; 2022 Mar; 29(2):e53-e64. PubMed ID: 33580780
[TBL] [Abstract][Full Text] [Related]
8. Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study.
Iida K; Tani S; Atsumi W; Yagi T; Kawauchi K; Matsumoto N; Hirayama A
Coron Artery Dis; 2017 Nov; 28(7):577-587. PubMed ID: 28692480
[TBL] [Abstract][Full Text] [Related]
9. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
Duncan MS; Vasan RS; Xanthakis V
J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
[TBL] [Abstract][Full Text] [Related]
10. Excess Apolipoprotein B and Cardiovascular Risk in Women and Men.
Johannesen CDL; Langsted A; Nordestgaard BG; Mortensen MB
J Am Coll Cardiol; 2024 Jun; 83(23):2262-2273. PubMed ID: 38839200
[TBL] [Abstract][Full Text] [Related]
11. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial.
Doi T; Langsted A; Nordestgaard BG
Atherosclerosis; 2024 Jun; 393():117556. PubMed ID: 38678642
[TBL] [Abstract][Full Text] [Related]
12. Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
Wadström BN; Wulff AB; Pedersen KM; Nordestgaard BG
Curr Atheroscler Rep; 2023 Nov; 25(11):795-803. PubMed ID: 37768410
[TBL] [Abstract][Full Text] [Related]
13. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
[TBL] [Abstract][Full Text] [Related]
14. Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
Wu F; Juonala M; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Burns TL; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Magnussen CG
Circulation; 2024 Jan; 149(3):217-226. PubMed ID: 38014550
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis.
Lamprea-Montealegre JA; Katz R; Scharnagl H; Silbernagel G; März W; Drechsler C; Wanner C; de Boer IH
Am J Cardiol; 2021 Aug; 152():63-68. PubMed ID: 34108090
[TBL] [Abstract][Full Text] [Related]
16. Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease.
Hedegaard BS; Bork CS; Kaltoft M; Klausen IC; Schmidt EB; Kamstrup PR; Langsted A; Nordestgaard BG
J Am Coll Cardiol; 2022 Nov; 80(21):1998-2010. PubMed ID: 36396201
[TBL] [Abstract][Full Text] [Related]
17. VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins.
Balling M; Afzal S; Varbo A; Langsted A; Davey Smith G; Nordestgaard BG
J Am Coll Cardiol; 2020 Dec; 76(23):2725-2735. PubMed ID: 33272366
[TBL] [Abstract][Full Text] [Related]
18. Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals.
Nordestgaard LT; Christoffersen M; Afzal S; Nordestgaard BG; Tybjærg-Hansen A; Frikke-Schmidt R
Clin Chem; 2021 Jan; 67(1):245-255. PubMed ID: 33418579
[TBL] [Abstract][Full Text] [Related]
19. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
[TBL] [Abstract][Full Text] [Related]
20. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
Doi T; Langsted A; Nordestgaard BG
Atherosclerosis; 2023 Aug; 379():117141. PubMed ID: 37217436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
